Lasa Supergenerics is currently trading at Rs. 60.00, up by 2.10 points or 3.63% from its previous closing of Rs. 57.90 on the BSE.
The scrip opened at Rs. 58.90 and has touched a high and low of Rs. 61.70 and Rs. 58.85 respectively. So far 25346 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 92.90 on 15-Jun-2021 and a 52 week low of Rs. 38.15 on 29-Mar-2022.
Last one week high and low of the scrip stood at Rs. 61.70 and Rs. 55.90 respectively. The current market cap of the company is Rs. 244.04 crore.
The promoters holding in the company stood at 43.78%, while Non-Institutions held 56.21% stake in the company.
Lasa Supergenerics has secured a new order of Rs 50 crore from just 5 customers. Such a huge order in the beginning of the financial year shall help the company to boost its production and contribute to the top line of company. Besides day-to-day business this bulk order will flood company’s order books yet again for this fiscal which shall help the company not only to recover the losses incurred in the last financial year due to Natural Calamities but also to contribute towards bottom line and achieve even greater heights.
Lasa Supergenerics is pioneer and amongst the leading players in the manufacturing of APIs in India through its catalyst chemistry expertise and fully backward integrated unit.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1521.95 |
Dr. Reddys Lab | 6279.95 |
Cipla | 1407.55 |
Zydus Lifesciences | 963.50 |
Lupin | 1640.30 |
View more.. |